Selected research
Industry Research
Liposome Development and Manufacturing Service Industry Research Report 2026
Market perspective
The global Liposome Development and Manufacturing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Liposome Development and Manufacturing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Liposome Development and Manufacturing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Liposome Development and Manufacturing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Liposome Development and Manufacturing Service include Baxter BioPharma Solutions, Charles River Laboratories, Evonik, Fresenius Kabi, Fujifilm, GEA and Intertek, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Liposome Development and Manufacturing Service market in terms of revenue (US$ million) and, where applicable, service volume (t), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Liposome Development and Manufacturing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Liposome Development and Manufacturing Service Market by Company
Baxter BioPharma Solutions
Charles River Laboratories
Evonik
Fresenius Kabi
Fujifilm
GEA
Intertek
Liposome Development and Manufacturing Service Segment by Type
Thaw Type
Freeze-dried
Liposome Development and Manufacturing Service Segment by Application
Cosmetic
Agriculture
Food
The Medical
Other
Liposome Development and Manufacturing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Development and Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Development and Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Development and Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Liposome Development and Manufacturing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Thaw Type
- Freeze-dried
Applications
- Cosmetic
- Agriculture
- Food
- The Medical
- Other
Companies covered
- Baxter BioPharma Solutions
- Charles River Laboratories
- Evonik
- Fresenius Kabi
- Fujifilm
- GEA
- Intertek
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Liposome Development and Manufacturing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Thaw Type
- 2.2.3 Freeze-dried
- 2.3 Liposome Development and Manufacturing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cosmetic
- 2.3.3 Agriculture
- 2.3.4 Food
- 2.3.5 The Medical
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Liposome Development and Manufacturing Service Breakdown Data by Type
- 3.1 Global Liposome Development and Manufacturing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Liposome Development and Manufacturing Service Forecasted Market Size by Type (2027-2032)
4 Liposome Development and Manufacturing Service Breakdown Data by Application
- 4.1 Global Liposome Development and Manufacturing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Liposome Development and Manufacturing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Liposome Development and Manufacturing Service Market Perspective (2021-2032)
- 5.2 Global Liposome Development and Manufacturing Service Growth Trends by Region
- 5.2.1 Global Liposome Development and Manufacturing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Liposome Development and Manufacturing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Liposome Development and Manufacturing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Liposome Development and Manufacturing Service Market Dynamics
- 5.3.1 Liposome Development and Manufacturing Service Industry Trends
- 5.3.2 Liposome Development and Manufacturing Service Market Drivers
- 5.3.3 Liposome Development and Manufacturing Service Market Challenges
- 5.3.4 Liposome Development and Manufacturing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Liposome Development and Manufacturing Service Players by Revenue
- 6.1.1 Global Top Liposome Development and Manufacturing Service Players by Revenue (2021-2026)
- 6.1.2 Global Liposome Development and Manufacturing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Liposome Development and Manufacturing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Liposome Development and Manufacturing Service Head Office and Area Served
- 6.4 Global Liposome Development and Manufacturing Service Players, Product Type & Application
- 6.5 Global Liposome Development and Manufacturing Service Manufacturers Established Date
- 6.6 Global Liposome Development and Manufacturing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Liposome Development and Manufacturing Service Market Size (2021-2032)
- 7.2 North America Liposome Development and Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Liposome Development and Manufacturing Service Market Size by Country (2021-2026)
- 7.4 North America Liposome Development and Manufacturing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Liposome Development and Manufacturing Service Market Size (2021-2032)
- 8.2 Europe Liposome Development and Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Liposome Development and Manufacturing Service Market Size by Country (2021-2026)
- 8.4 Europe Liposome Development and Manufacturing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Liposome Development and Manufacturing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Liposome Development and Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Liposome Development and Manufacturing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Liposome Development and Manufacturing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Liposome Development and Manufacturing Service Market Size (2021-2032)
- 10.2 South America Liposome Development and Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Liposome Development and Manufacturing Service Market Size by Country (2021-2026)
- 10.4 South America Liposome Development and Manufacturing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Liposome Development and Manufacturing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Liposome Development and Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Liposome Development and Manufacturing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Liposome Development and Manufacturing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Baxter BioPharma Solutions
- 12.1.1 Baxter BioPharma Solutions Company Information
- 12.1.2 Baxter BioPharma Solutions Business Overview
- 12.1.3 Baxter BioPharma Solutions Revenue in Liposome Development and Manufacturing Service Business (2021-2026)
- 12.1.4 Baxter BioPharma Solutions Liposome Development and Manufacturing Service Product Portfolio
- 12.1.5 Baxter BioPharma Solutions Recent Developments
- 12.2 Charles River Laboratories
- 12.2.1 Charles River Laboratories Company Information
- 12.2.2 Charles River Laboratories Business Overview
- 12.2.3 Charles River Laboratories Revenue in Liposome Development and Manufacturing Service Business (2021-2026)
- 12.2.4 Charles River Laboratories Liposome Development and Manufacturing Service Product Portfolio
- 12.2.5 Charles River Laboratories Recent Developments
- 12.3 Evonik
- 12.3.1 Evonik Company Information
- 12.3.2 Evonik Business Overview
- 12.3.3 Evonik Revenue in Liposome Development and Manufacturing Service Business (2021-2026)
- 12.3.4 Evonik Liposome Development and Manufacturing Service Product Portfolio
- 12.3.5 Evonik Recent Developments
- 12.4 Fresenius Kabi
- 12.4.1 Fresenius Kabi Company Information
- 12.4.2 Fresenius Kabi Business Overview
- 12.4.3 Fresenius Kabi Revenue in Liposome Development and Manufacturing Service Business (2021-2026)
- 12.4.4 Fresenius Kabi Liposome Development and Manufacturing Service Product Portfolio
- 12.4.5 Fresenius Kabi Recent Developments
- 12.5 Fujifilm
- 12.5.1 Fujifilm Company Information
- 12.5.2 Fujifilm Business Overview
- 12.5.3 Fujifilm Revenue in Liposome Development and Manufacturing Service Business (2021-2026)
- 12.5.4 Fujifilm Liposome Development and Manufacturing Service Product Portfolio
- 12.5.5 Fujifilm Recent Developments
- 12.6 GEA
- 12.6.1 GEA Company Information
- 12.6.2 GEA Business Overview
- 12.6.3 GEA Revenue in Liposome Development and Manufacturing Service Business (2021-2026)
- 12.6.4 GEA Liposome Development and Manufacturing Service Product Portfolio
- 12.6.5 GEA Recent Developments
- 12.7 Intertek
- 12.7.1 Intertek Company Information
- 12.7.2 Intertek Business Overview
- 12.7.3 Intertek Revenue in Liposome Development and Manufacturing Service Business (2021-2026)
- 12.7.4 Intertek Liposome Development and Manufacturing Service Product Portfolio
- 12.7.5 Intertek Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst